Drug Profile


Alternative Names: Klerval™; RPR 109891

Latest Information Update: 26 Nov 1999

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Aventis
  • Class Antiplatelets
  • Mechanism of Action GPIIb-IIIa antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Myocardial infarction

Most Recent Events

  • 30 Sep 1999 A study has been added to the Ischaemic Heart Disease and Thromboses therapeutic trials sections
  • 09 Nov 1998 Discontinued-II for Myocardial infarction in Europe (IV)
  • 09 Nov 1998 Discontinued-II for Myocardial infarction in Europe (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top